Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

被引:0
|
作者
Ginoza, M [1 ]
Marques, A [1 ]
Cesaretti, M [1 ]
Zanella, M [1 ]
Ribeiro, A [1 ]
Kohlmann, O [1 ]
机构
[1] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [21] Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat
    Kubota, E
    Dean, RG
    Hubner, RA
    Casley, DJ
    Johnston, CI
    Burrell, LM
    CLINICAL SCIENCE, 2003, 105 (03) : 339 - 345
  • [22] Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in rat
    Kubota, E
    Dean, RG
    Hubner, RA
    Johnston, CI
    Casley, DJ
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2002, 20 : S247 - S247
  • [23] Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease
    Dudman, N
    Hunt, D
    MacMahon, S
    Neal, B
    Richards, M
    Simes, J
    Tonkin, A
    Wilcken, D
    Murphy, J
    Cleverly, Y
    Keech, A
    Ohkubo, T
    Brnabic, A
    Tonkin, A
    Bos, K
    Bartram, H
    Bennett, D
    Broad, J
    Douglas, D
    Fisher, S
    Gray, B
    Milne, A
    McCulloch, A
    Ng, C
    Pledger, M
    Pryor, A
    Santos, A
    Slater, A
    Yiu, K
    Woodward, M
    Burrell, L
    Brown, L
    Hamer, A
    Roberts, L
    Jeffery, I
    Taverner, P
    Kam, A
    Aylward, P
    Wollaston, F
    Whitehead, A
    Lane, G
    Tulloch, G
    Forrest, N
    Garrett, J
    Aroney, G
    Hicks, P
    Silberberg, J
    Gordon, A
    Holliday, J
    Hicks, L
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2002, 3 (04) : 270 - 276
  • [24] The effects of omapatrilat on cardiac hypertrophy and brain natriuretic peptide concentration in spontaneously hypertensive rats
    Wei, C
    Dong, Y
    Lin, R
    JOURNAL OF HYPERTENSION, 2002, 20 : S285 - S285
  • [25] Systemic characterization of metabolic and cardiovascular rhythms in spontaneously hypertensive rats
    Kohsaka, Akira
    Cui, He
    Waki, Hidefumi
    Bhuiyan, Mohammad E. R.
    Gouraud, Sabine S.
    Maeda, Masanobu
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2010, 60 : S183 - S183
  • [26] Vasopeptidase inhibitor, omapatrilat, improved cardiac function and remodelling in rats with chronic heart failure
    Maki, T
    Nasa, Y
    Tanonaka, K
    Takeo, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 78P - 78P
  • [27] Anti-apoptotic effect of the vasopeptidase inhibitor omapatrilat in rats with acute myocardial infarction
    El Mokhtari, NE
    Meissner, A
    Reinecke, A
    Krueger, D
    Lins, M
    Tiroke, A
    Simon, R
    EUROPEAN HEART JOURNAL, 2002, 23 : 203 - 203
  • [28] Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects
    Liao, WC
    Vesterqvist, O
    Delaney, C
    Jemal, M
    Ferreira, I
    Ford, N
    Swanson, B
    Uderman, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 395 - 406
  • [29] Beneficial effects of the vasopeptidase inhibitor omapatrilat on neurogenic volume retention in rats with experimental congestive heart failure (CHF)
    Klanke, B
    Karl, HF
    Ditting, T
    Schmieder, RE
    Veelken, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 512A - 512A
  • [30] CARDIOVASCULAR EFFECTS OF PRAZOSIN IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR)
    CAVERO, I
    LEFEVRE, F
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1976, : 61 - 64